Encompass Health CORP (EHC) Institutional Investor Snapshot (600 Funds, Q2 2026)

EHC ranks #947 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

EHC is a top-conviction position for Eversept Partners, LP — at 5.4% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in EHC belongs to BlackRock, Inc., but the position matters far more to Eversept Partners, LP, who has 5.4% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

Ken Griffin has added to its EHC position for two straight quarters, increasing it by $251.2M to reach $265.2M today.

Invesco Ltd. has trimmed its EHC position for two straight quarters, cutting it by $410.4M while still holding $117.4M.

EHC is down 0.7% today, but institutions show net buying of $1.1B this quarter — a divergence between today's price move and the underlying institutional flow.

EHC posted net income of $621.0M over the trailing twelve months, and currently trades at a P/E of 19.9.

• Profitable — net income of $621.0M over the trailing twelve months
• Revenue grew 9.5% year over year
• Net income improved year over year, from $522.7M to $621.0M
• Generated $1.2B in positive operating cash flow
• Current ratio of 1.08x — below the conventional 1.5x liquidity buffer
• Liabilities run 1.56x equity — within a conventional range